Janssen wins Mylan ANDA row as US appeals court affirms infringement
MLex Summary: The US Court of Appeals for the Federal Circuit found in favor of Jannsen Pharmaceuticals in its patent row with Mylan Laboratories, affirming a District of New Jersey decision...To view the full article, register now.
Already a subscriber? Click here to view full article